SBIR/STTR Research Award

Triggered-Suggestion Device with Therapy for Weight Loss

Award identifier 5f816cab7aa55ea0b2971968fc4030f8296265818e9dfee18ab0348fcdd133a7Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$119,091

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PROGENESIS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Obesity represents a significant public health concern and is associated with medical complications that include premature mortality. The proposed Phase I study will evaluate the feasibility of the Triggered Suggestion Device (TSD) as a therapeutic aid in the behavioral treatment of overweight individuals. The TSD is a custom wristwatch that provides visual, auditory, and tactile cueing to the wearer. Signals from the TSD are linked to therapeutic goals that are developed with a therapist/counselor and augmented with an audio CD that is focused on weight loss and healthy living. Individuals with BMIs of 25 to 35 will be recruited and randomly assigned to one of two experimental groups, behavioral therapy alone or behavioral therapy plus the TSD. After 8 weeks of treatment, the following primary and secondary variables will be measured: change in BMI, satisfaction with treatment method, change in physical activity, and life satisfaction rating. Study results will provide significant support for the commercial viability of the TSD as a therapeutic tool for weight loss. Strong anecdotal evidence from psychotherapists supports the application of the TSD to weight loss and further scientific investigation is warranted. PROPOSED COMMERCIAL APPLICATION: The TSD will be of value to mental health professionals and physicians who provide treatment for weight loss, clinical eating disorders, and patients with weight-related illnesses. Its nonpharmaceutical design makes it an appropriate choice for groups such as adolescents and pregnant women. The TSD is currently in commercial production under the brand name "HabitEX- Manage Your Weight Successfully" and is being used in private psychotherapy practices.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.